Suchergebnisse - "Galassi, Andrea"

PubPharm (147)

31

SARS-CoV-2-related ARDS in a maintenance hemodialysis patient : case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point-of-care ultrasound

enthalten in: Clinical case reports | 2021

von Galassi, A. | Casanova, F. | Gazzola, L. | +16

32

Dabigatran overload in acute kidney injury : haemodialysis or idarucizumab? A case report and proposal for a decisional algorithm

enthalten in: Clinical kidney journal | 2021

von Galassi, A. | Podda, G. | Monciino, P. | +3

CommentIn: Clin Kidney J. 2020 Mar 11;14(2):710-711. - PMID 35261760

33

COVID-19 in a dialysis center in Milan from March to June 2020 : understanding how to respond to the second wave of the pandemic

enthalten in: Journal of nephrology | 2021

von Galassi, A. | Magagnoli, L. | Cozzolino, M. | +1

34

Do we need new phosphate binders in dialysis?

enthalten in: Clinical kidney journal | 2021

von Cozzolino, M. | Galassi, A. | Ciceri, P.

35

COVID-19 in a dialysis center in Milan from March to June 2020: understanding how to respond to the second wave of the pandemic

enthalten in: Journal of nephrology | 2021

von Galassi, A. | Magagnoli, L. | Cozzolino, M.

36

COVID-19 in a dialysis center in Milan from March to June 2020: understanding how to respond to the second wave of the pandemic

enthalten in: Journal of nephrology / Supplement | 2021

von Galassi, A. | Magagnoli, L. | Cozzolino, M.

37

COVID-19 in a dialysis center in Milan from March to June 2020: understanding how to respond to the second wave of the pandemic

enthalten in: Journal of nephrology | 2021

von Galassi, A. | Magagnoli, L. | Cozzolino, M.

38

COVID-19 in Chronic Kidney Disease : The Impact of Old and Novel Cardiovascular Risk Factors

enthalten in: Blood purification | 2021

von Podestà, M. | Valli, F. | Galassi, A. | +5

39

Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients : a prospective, cross-over study

enthalten in: Clinical kidney journal | 2021

von Cozzolino, M. | Magagnoli, L. | Ciceri, P. | +2

40

Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency

enthalten in: Expert opinion on drug safety | 2021

von Galassi, A. | Ciceri, P. | Porata, G. | +8